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Abstract
Polycystic ovary syndrome (PCOS) is an endocrine system disorder that affects women
of reproductive age. If not treated properly, PCOS can lead to infertility. Lack of proper
treatment of PCOS may also result in medical complications such as diabetes or heart
disease. The rural clinic where this project took place did not have a mandatory guideline
for treatment of PCOS; therefore, no standardized method of diagnosis or treatment of
PCOS existed. The purpose of this project, guided by the IOWA evidence-based practice
model, was to educate providers on the evidence-based guideline for diagnosis and
treatment of PCOS outlined by the Endocrine Society Taskforce. The guideline was
selected after a comprehensive literature review and was used to develop an educational
program that was provided to 5 nurse practitioners, the medical director and staff. A pretest post-test design was used to determine if the participants understood the content from
the guideline that was presented. Results showed that the researcher-developed test
administered to participants yielded scores of 74 on the pre-test and increased after the
education program with all participants scoring 100 on the post-test. The guideline used
for the education was then presented to the clinic for implementation with the assistance
of the medical director’s support. The project provided an evidence-based guideline for
diagnosing and treating PCOS and raised awareness of PCOS among all staff in a rural
clinic where many patients with PCOS are treated. Positive social change may result as
providers are better prepared to deliver evidence-based care for PCOS and as infertility
and complications of untreated PCOS are reduced.
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Section 1: Nature of the Project
Introduction
Polycystic ovary syndrome (PCOS) is an endocrine disorder that can affect a
woman’s ovaries and reproductive system (Mayo Clinic, 2016). When a woman has
PCOS and it is not managed appropriately, it can affect her ability to conceive. The exact
cause of PCOS is unknown. Factors that play a role in the development of PCOS include
excess insulin, low-grade inflammation, and hereditary (Mayo Clinic, 2016). Scholars
have compared the recommendation of lifestyle changes (diet/exercise) as opposed to
treatment with clomiphene and Metformin for infertility (Fica, Alba, Constantin, &
Dobri, 2008). Metformin is a drug that is used to treat Type 2 diabetes by improving the
way that the body handles insulin (Diabetes Self-Management, 2016). Clomiphene is a
fertility medicine that affects the pituitary gland (Drugs.Com, 2016). Researchers have
also examined menstrual patterns and body mass index (BMI) as they relate to increased
fertility after starting Metformin versus lifestyle modifications only (Curi et al, 2012).
Curi et al. (2012) showed that menstrual pattern improved in both groups: however, there
was a significant decrease in BMI in the lifestyle change only group. The implementation
of mandatory guidelines within a practice may result in improved care and increased
fertility. Clinical practice guidelines can improve the quality of care and this has been
demonstrated by rigorous evaluations. Clinical practice guidelines are designed as
recommendations about the care of patients within conditions provided to clinicians (UpTo-Date, 2016). Their intent is to optimize patient care. Guidelines have changed focus
from the effectiveness of interventions to the size of the effect and balance between
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effects and cost (Up-To-Date, 2016). The Endocrine Society Task Force (2013)
developed guidelines to treat PCOS. These guidelines are not always followed by
obstetric and gynecology physicians and providers. The Endocrine Society Task Force
guidelines first recommended using Rotterdam criteria for diagnosing PCOS (as cited in
Legro, 2016). This includes the presence of two of the following criteria: ovulatory
dysfunction, androgen excess, or polycystic ovaries (Legro, 2016). For women who are
not trying to conceive, hormonal contraceptives are the first line of management for
PCOS. Clomiphene, which is used to induce ovulation, is currently the first-line therapy
for infertility (Legro, 2016). Metformin is beneficial, in conjunction to the clomiphene,
for improving menstrual abnormalities (Legro, 2016). The recommendation of exercise
therapy and dietary intention is also found within these guidelines. The specifics of
certain diet modifications are addressed in the guidelines. After becoming pregnant
Metformin is recommended as a first-line treatment for prevention of pregnancy
complications (Legro, 2016).
Problem Statement
Infertility is a problem that many women face. Infertility is considered a disease
of the reproductive system, and it is defined by failure to achieve clinical pregnancy
within 12 months of unprotected sexual intercourse (World Health Organization, 2016).
Women can have infertility problems that start years prior to the diagnosis. They are
usually not recognized until the couple is trying to conceive. Infertility issues should be
addressed, evaluating both the male and female for issues. PCOS is one of the causes of
infertility. Most providers will not start evaluating the problem until the woman has been
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trying to become pregnant for more than 12 months (Sherbahn, 2016). For women over
the age of 35, earlier evaluation and treatment may be justified based on medical history
and physical findings and is warranted after 6 months (Sherbahn, 2016). Not identifying
the cause of the problem can delay treatment and the likelihood of becoming pregnant. At
the age of 35, fertility declines, which makes it even more important for these patients to
receive proper treatment. Some women may miss this window of opportunity to
conceive if the PCOS is not managed properly from the start of diagnosis.
Purpose Statement
The purpose of this project was to educate providers with the proper guidelines
for the treatment for PCOS. Identification of why it is important to implement these
proper guidelines was established. I evaluated increased fertility, decreased BMI, and
decreased insulin levels from an organizational standpoint; however, I also outlined a
successful planning phase for this organizational. The Endocrine Task Force (2013)
formulated practice guidelines for the treatment of PCOS; however, providers do not
usually follow these recommendations.
Women with PCOS are at higher risk for many health problems. These health
problems include pregnancy complications, endometrial cancer, obesity, depression,
obstructive sleep apnea, fatty liver, Type 2 diabetes, and cardiovascular risk (Legro,
2016). Educating providers on the treatment of PCOS may make them more willing to
follow guidelines when treating these patients. Providers require skills and knowledge in
order to provide competent care to protect people using the health care system. Health
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care education is one key to ensuring quality of life, improving patient outcomes, and
protecting individuals from harm (Grimm, 2014).
Nature of Doctoral Project
The purpose of this doctoral project was to demonstrate advanced knowledge in
the area of nursing, research, and evidence-based practice. This project has laid the
foundation for future scholarship. This project allowed me to demonstrate my
achievement of the 8 DNP essentials. I believe that this project is the beginning of many
scholarly contributions in the future. The other goal of this project was to reiterate to
providers the purpose of guidelines and their use. Guidelines are set in place to guide
practice although each individual should be addressed as an individual. These guidelines
are validated through evidence and should be used as much as possible.
Significance
Proper treatment for PCOS is a significant problem. PCOS is a prevalent disorder.
PCOS affects 5-10% of women of childbearing age (20-40) and 30% of women have
PCOS symptoms (Health Grades, 2014). This age range is a critical part in a woman’s
life to produce life and have a family. Proper treatment during this stage, or prior, in a
women’s life could be the difference between becoming pregnant and not becoming
pregnant. Providers play a role in the decision-making process for treatment plans for
these women. Providers need to make the appropriate recommendations for these women
based on what evidence has shown. The infertility rate for women with PCOS is high
and each additional year or time wasted on improper treatment or lack of diagnosis
increases these rates. Proper education and proper guideline adherence will lead to proper
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treatment and increased fertility. For this project, my focus was on the planning portion
for provider education and algorithm/guideline use. As the organization continues to
carry out the project with their patients, they should see an increase in fertility, decrease
BMI, and decrease insulin levels. As the BMI and insulin levels decreases, so does the
risk for the complications of PCOS.
Summary
PCOS is a common condition. It is associated with many complications. Scholars
have identified different treatment modalities that can provide better outcomes. Having
clinical guidelines in place can assist medical providers with caring for these patients.
The problem addressed in this project was the complications that are seen when women
do not receive proper treatment. The purpose of this project was to educate the providers
on the use of the Endocrine Task Force guidelines. Statistical data were produced to show
the significance of this disorder and it prevalence. Implementing the proper guidelines
will ensure timely treatment as well as improve patient satisfaction.
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Section 2: Background and Context
Introduction
Infertility related to PCOS continues to affect many women in the United States.
The purpose of this evidence-based practice project was to improve health care delivery.
In this study I sought to discover the effectiveness of the quality improvement planning
regarding the adoption of the PCOS practice guidelines/algorithm and the educational
program. Theories that were used as frameworks for this project were the Lewis Change
theory as well as the IOWA model.
Concepts, Models, and Theories
The use of the IOWA model was beneficial for use in this quality improvement
project. The focus of the IOWA model is on collaboration and organization incorporating
conduct and the use of research along with other types of evidence (Doody & Doody,
2011). It was introduced in 1994 and is used in research programs and is in nursing
journals (Doody & Doody, 2011). This model focuses on problem-focused triggers and
knowledge that drives staff to begin to question if there is a better way of doing things
(Doody & Doody, 2011). The IOWA model is composed of seven steps: selection of a
topic, forming of a team, evidence retrieval, grading the evidence, developing an
evidenced-based practice (EBP) standard, implementing the EBP, and evaluation (Doody
& Doody, 2011). Each step was implemented during the project.
Another theory or model selected to drive this EBP quality improvement project
of improving healthcare delivery was the Lewis change model. Lewis change theory
includes an examination of change as a process with three distinct stages (Mindtools,
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2017). The Lewis change model was developed in the 1940s by Lewis (Mindtools, 2017).
The Lewis model has three stages: the unfreeze stage, the change stage, and the refreeze
stage (Mindtools, 2017). The first stage is the unfreeze stage. During this stage, the
organization is prepared to accept that a change is needed (Mindtools, 2017). During the
unfreezing stage, the existing status quo is broken down in order to build up a new way of
doing things (Mindtools, 2017). The next step of the Lewis change theory is the change.
This stage is also called the movement. During the change stage, some of the persons
involved may have an unsure feeling; however, that unsure feeling begins to resolve in
the change stage. During the change stage, people begin to support the new direction
(Mindtool, 2017). Although the transition is not easy, people start to believe and behave
in ways that support the new direction (Mindtool, 2017). The last stage of Lewis change
theory is the refreeze stage. During this stage, people embrace the new way of doing
things (Mindtools, 2017). In completing this project, the goal was for the medical
providers to embrace the new information acquired during education, as well as the
adoption of the guideline/algorithms. For this project, the change that was needed was for
women to obtain the proper diagnosis and treatment of PCOS. Proper treatment of PCOS
can increase fertility rates, improve insulin levels, and lower BMIs. The goal was met
with success with the implementation of the guidelines.
Relevance to Nursing Practice
Awareness of PCOS has been an ongoing problem. Medical providers do not
always order the necessary test that aid in making the appropriate diagnosis (Parker,
2015). Some medical providers are not aware of its potential consequences including
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infertility. When women have PCOS that is undiagnosed or untreated, they may have
anovulation (not releasing eggs or ovulating) and/or they could have ovaries that contain
small cystic structures (Sherbahn, 2016). This is why it is important to diagnose and
begin treatment with these women. The infertility rate of women with PCOS is high.
Many will require treatment to aid with pregnancy (Sherbahn, 2016). Women with PCOS
are also at higher risk for other medical problems. Some of the other complications
associated with PCOS include hypertension, high cholesterol, anxiety, depression, sleep
apnea, heart attack, diabetes, and breast cancer (Mayo Clinic, 2016). These potential
complications make this diagnosis and need for change relevant to nursing practice.
Organizations that attempt to bring awareness to PCOS treatment are not widely
supported. These organizations receive only less than 1% of funding (Parker, 2015).
Limited funding can lead to the condition crossing disciples and falling through the
cracks. Educating those providing the care may help them to combat some of these
complications as well as decrease infertility.
Local Background and Context
The practice setting for this project was a rural outpatient clinic whose patient
population varied. This office has patients with a wide range of ages as well as a variety
of races. Patients are seen at the project site as gynecological patients and may receive the
diagnosis of PCOS. Providers can implement the recommended treatment plan per the
developed guidelines/algorithm. On a national level, many women are affected by
PCOS. It is imperative to establish more of a mandatory guide as well as to educate
providers caring for these patients. The Endocrine Society Task Force has established

9
diagnostic criteria, as well as treatment guidelines. Many studies have been performed
on treatment of PCOS. According to Pamela Montplaisir (2011), the medication
Metformin can be used in women with PCOS to help induce ovulation although its
primary use is for the treatment of Type 2 diabetes. Metformin can increase the
functionality of the ovaries as well as improve insulin sensitivity (Kurzthaler &
Hadziomerovic-Pekic, 2015). Many women who would like to become pregnant, but
have PCOS, are placed on Metformin to help with fertility; however, scholars also show
that weight loss, even modest weight loss has proven to be an efficient method to
improve reproductive parameters in PCOS patients (Fica, Albu, Constantin, & Dobri,
2008). Practitioners can use evidence-based guidelines to ameliorate the quality of care of
patients by adhering to interventions of proven benefit, while discouraging interventions
that are not effective (Limb et al, 2016).
Role of DNP Student
My role as a DNP student in this project was to first prove the need. Again,
clinical practice guidelines should be followed when treating patients. This ensures that
the patients are receiving optimum care. The nurse practitioners in this practice had the
choice of using guidelines or their own treatment plan. I was able to prove the need for
the use of the guidelines. I was also able to provide the educational materials. I
developed all of the test and surveys as well as held the meetings with stakeholders. I
was able to prove to the medical director that this need existed based on the evidence
provided.
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Role of Project Team
The project team for this EBP quality improvement project consisted of an
educator, chief executive officer (CEO), office manager, and medical providers for the
student portion. The project teams that will continue to carry out the project for the
organization consist of consenting patients, medical providers, and nurses. Each person
involved on the project team will play a role in this project. The medical providers will
be treating the patients with PCOS and following the guideline/algorithm. I designed the
guideline/algorithm based on EBP. The educator taught the class that discusses PCOS in
detail to the providers who will be treating the patients. The educator also discussed the
guideline/algorithm that will be used. The patients will be those who consent to be a part
of this project. The nurses will be collecting the data needed for this project. The nurses
will document all of the information gathered and continue for 1-year post
implementation. The project will take place over the course of a year; however, my
project extended only through the planning phase.
Summary
PCOS diagnosis and treatment is relevant in the medical community. In this
project I used models and theories such as the IOWA model and Lewis change theory for
its implementation. In order to improve outcomes for this condition, the project team was
selected to carry out this project. After its completion in 1 year we should see an
improvement in health as well as increased fertility in these women. After the completion
of my portion it was determined that the project was a well-planned project on current
healthcare practice within this organization. It included proper planning for the meetings,
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synthesis of evidence, national guideline review, cost benefit investigation/analysis, and
stakeholder satisfaction.
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Section 3: Collection and Analysis of Evidence
Introduction
Undiagnosed PCOS and improper treatment continues to be an ongoing problem.
Because PCOS can lead to infertility as well as other serious medical conditions,
educating providers, as well as creating a policy for them to follow is important. Women
with PCOS are at high risk of long-term complications (Terrie, 2004). In this project I
sought to address this issue through education and guidelines. Tools from the literature
were used as well as recommendations from the Endocrine Society Task Force to guide
this project. The purpose of this section is to discuss the collection as well as the analysis
of the evidence for this project. In this section, I will address the practice focused
questions for this project. I will also explain the sources of evidence gathered from the
literature. In the last section I will discuss the analysis and synthesis process in detail.
Practiced-Focused Questions
The purpose of this EBP project was to improve healthcare delivery. The overall
quality improvement EBP project was multifaceted and complex, and it will continue to
require a long-term commitment from the organization. The practice-focused questions
were separated below to outline the umbrella plan for the organization and the portion of
that plan that I addressed within the time-constraints of this doctoral program.
Organizational Standpoint: Longview
This practice question is at the organizational level, is comprehensive, and shows
the larger picture of this project that went beyond the scope of my work.
Among females aged 18-45 years old with BMIs >30, an infertility diagnosis, and
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seeking care in a rural area clinic in Eastern United States, how does the adoption of a
Polycystic Ovary Syndrome (POS) practice guideline/algorithm and an educational
program for providers, per the POS Diagnosis and Treatment Guidelines (per the
Endocrine Society Task Force http://press.endocrine.org/doi/abs/10.1210/jc.20132350) including medication and/or lifestyle change interventions, impact fertility rates,
BMI levels, and insulin levels as measured 1 year post implementation compared to
current practice of providers choosing their own treatment plan.
My Standpoint: Short view
The DNP practice question is specific to the planning phase for the aforementioned
broad, organization-wide project.
Among females aged 18-45 years old with BMIs >30, an infertility diagnosis, and
seeking care in a rural area clinic in Eastern United States, how effective was the quality
improvement planning regarding the adoption of the POS practice guideline/algorithm
and an educational program for providers, per the POS Diagnosis and Treatment
Guidelines (per the Endocrine Society Task
Force http://press.endocrine.org/doi/abs/10.1210/jc.2013-2350) as measured by the end
of the DNP program based on the following
Formative outcomes achievements (e.g. evaluation of current healthcare
practice within the organization, initiation of stakeholder meetings, synthesis and
leveling of evidence, national clinical guideline reviews (Endocrine Society Task
Force), agency policy analysis, development of draft agency-specific evidencebased guidelines, stakeholder content validity index evaluations of policy/practice
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change recommendations, expert content review of education materials created,
secondary analysis of existing agency data on the problem, cost-benefit
investigation)
Summative outcomes achievements (e.g., final cost-benefit analysis,
recommended solutions including final agency policy revision proposal, final
health care professional education module, pre-post implementation outcome
measurement strategy, stakeholder satisfaction with DNP project leadership)
Sources of Evidence
Clinical practice guidelines are used to improved quality care while reducing
healthcare cost (Keffer, 2001). There are over 800 publications of guidelines for medical
providers (Keffer, 2001). Although it may be difficult to keep up with the number of
guidelines that are in place, they still play a role in the guidance of patient care. In
contrast to guidelines, algorithms help to simplify things. Guidelines are set in place to
help guide the medical provider in their decision making for treatment plans; however,
they are not in place to take away the need to individualize the care of patients. This is
often seen with other chronic diseases such as diabetes and hypertension. The Eighth
Joint National Committee (JNC 8) guidelines are in place to help the provider in the
management of hypertension; most health care providers follow it. The American
Association of Clinical Endocrinologist (AACE) guidelines are in place for diabetes
management. Most medical providers also follow it.
The problem with PCOS treatment is that many medical providers are not familiar
with the proper diagnosis criteria or the treatment (Parker, 2015). Some medical

15
providers are not aware that there are also guidelines in place for the diagnosing,
management, and treatment of PCOS. The Endocrine Society Task Force has produced
guidelines to help providers treat women with this diagnosis. However, guidelines are
inconsistently implemented and used (American College of Surgeons, 2006). For women
with PCOs this is a problem. The time between a woman being diagnosed and treated
can be the difference between if the women will be able to conceive or not. Medical
providers can use of a guideline/algorithms and measure key markers such as BMI,
insulin levels, and number of positive pregnancies when diagnosing and treating PCOS.
Participates
The evidence generated for this project was done so strategically. The
participants have to meet several qualifying criteria. They must be female. They must be
between the ages of 18-45. They must have the diagnosis of PCOS as well as a diagnosis
of infertility. Their BMI must be greater than 30. These criteria will make this selection
of participates relevant to the practice-focused questions for the organizational long view.
The selection process for participates will be carried out by the organization and are
beyond my duties. I focused on the persons involved in the planning for this project. This
included stakeholders such as the CEO, medical director, and office manager of the
practice. I looked to obtain buy-in for the project and the willingness for them to carry it
out to completion after the planning phase.
Procedures
I met with the CEO, medical director, and office manager to discuss this project.
I discussed the need for the project and explained the algorithm/guideline. Statistics were
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shared regarding PCOS, complications, its relation to infertility, and the need to follow
these guidelines. After establishing the need as well as the stakeholders being in
agreement with the project, I presented the algorithm and educational material. I also
discussed the costs associated with the project as well as the role that the organization
will play in carrying out the project once my planning portion was complete. The
medical providers, who will care for the patients, participated in a 30-minute educational
session. During this session the providers were educated/reviewed the diagnosis and
treatment of PCOS. The recommend guidelines per the Endocrine Society Task Force as
well as the algorithm that will be followed were also discussed. The organization will
carry out the rest of the steps that will include the selection of participates. They will be
selected based on the criteria previously discussed as well as them giving informed
consents. Participates will have baseline laboratory blood work collected and measured
prior to the initiation of any treatment. During the visits, the medical provider will initiate
the treatment as recommended per the guidelines/algorithm while taking each individual
patient into consideration. The women will come in monthly over the next year to have
key indicators measured. During these visits, modifications to therapy can also be made
and documented. Also, participates will have a pregnancy test done monthly. The
treatment for each patient will be documented.
Protections
Procedures that will be used to ensure the ethical protection of the participates
include the Health Insurance Portability and Accountability Act (HIPPA) standards.
These standards are followed daily in this doctor’s office and will remain in place for this
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project. All participates will have to fill out a consent from to participate in this project.
One strategy for recruiting participates would be to offer free treatment as well as
laboratory testing during the course of the project. This was discussed with the
stakeholders and will be carried out by them. I am not responsible for engaging in any
patient care/data collection nor am I responsible for that portion of the project. I was only
involved in meeting with the stakeholders and the planning portion of the project. The
organization will carry out the project and collect the data. The Institutional Review
Board (IRB) played a role in ensuring that the projects remained ethical. The IRB is
responsible for making sure that research from Walden University complies with U.S.
federal regulations as well as the university's ethical standards (Walden University
Centers for Research Quality, 2017).
Analysis and Synthesis
The systems used for recording the data will include the electronic medical
systems known as Success and another named Orchard. Success has the capability to
store the participates monthly visits. The visit documentation will include the vital signs
with the BMI, the medication list, and any symptoms reported by the patient. The
Orchard system contains all of the laboratory data. It has the capability of displaying
individual data as well as trends. These data will be analyzed in order to show an
improvement in PCOS when clinical guidelines are followed. For my portion of the
project, the pre and posttest results were used for analysis.
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Summary
Addressing the practice-focused questions and implementing the planning portion
for this project was not easy, but having a plan in place helped with the process. Prior to
implementing the project, the literature was reviewed on the benefits of using clinical
practice guidelines and algorithms. This information was presented to the stakeholders.
The method used ensured the validity of the results that were produced. The selection
process for participates was selective in order to meet the criteria needed for the practice focused questions. The participates will have to give consent to be apart of the study
with free treatment offered in returned from their participation. They are protected by
HIPPA as well as the IRB. The selected tools used such as the Success and Orchard
systems have been evaluated and proven to be effective for collecting and reporting data.
I will only be involved in the planning stage of this project.
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Section 4: Findings and Recommendations
Introduction
The improper diagnosis and treatment of PCOS can lead to many complications.
One of these complications includes infertility. According to statistics, 50% of women
with PCOS go undiagnosed (Health Grades, 2014). Health Grades (2014) also showed
that 50% of women with PCOS will develop pre diabetes by the age of 44. This quality
improvement EBP was multifaceted and complex and it continues to require a long-term
commitment from the organization. I explored the effect of the adaption of a PCOS
practice guideline/algorithm and education program. I was focused on the planning
phase of the project. The purpose of this project was to educate providers with the proper
guidelines for treatment of PCOS, identify why it is important to implement these
guidelines, and increase patient fertility while decreasing complications. Clinical
guidelines aim to achieve improved quality care while reducing healthcare cost (Keffer,
2001). These guidelines play a role in the guidance of patient care. Using a simple
questionnaire form of analysis, it was determined that more education was needed on
PCOS diagnosis and treatment. This further supported the need for the
algorithm/guideline use.
Findings and Implications
The pre education questionnaire consisted of questions taken from the Endocrine
Society Task Force Guidelines. These guidelines are the gold standard for diagnosing and
treating PCOS. The make-up of the questions was focused on proper diagnosis and
treatment of PCOS. The questionnaire consisted of 10 questions. These questions ranged
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from multiple choice, fill in the blank, and true/false type questions. I created and
administered the pre education questionnaire to five nurse practitioners in the practice
prior to the education sessions. The average score on the questionnaires came back at
74%. The lowest score on the pre questionnaire was a 60% and the highest score was a
90% (Appendix D). These findings further supported the need for education and
guidelines when diagnosing and treating PCOS. The medical director then led an
education session, which I developed. Persons present at the education session included
the nurse practitioners, as well as the other medical staff. The session included a
discussion of diagnosis and treatment of PCOS, as well as the guidelines/algorithm that
should be followed when a patient is diagnosed with PCOS per the Endocrine Society
Task Force. Nurses, certified nursing assistances, and medical assistants also took part in
the education session. After the nurse practitioners attended the education session, they
were retested. All of the nurse practitioners scored a perfect score (100%) and agreed
that the use of the guideline/algorithm would provide better outcomes for the patients
(Appendix D).
The nurse practitioners also agreed that its use would make them feel more
comfortable when diagnosing and treating these patients. The medical director of this
facility agreed to carry out the remainder of the project in his organization with policy
change at its completion. The remainder of the project will include implementing the
guidelines as discussed previously. The patients will come in monthly for testing and the
trends will be recorded. This will then support the need for the policy change.
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Based on discussion with the medical director, office manager, and other
stakeholders, I gained buy-in on the need for the policy change. The field of nursing has
many different levels. I focused more on the nurse practitioner level and advancing
nursing as a whole through education and use of the clinical guidelines. Guidelines are
readily available for nurses to use; however they are not always followed. When it comes
to topics such as PCOS, due to the lack of knowledge, nurse practitioners and other
providers need policies that mandate their use.
One limitation that could have impacted the findings was the years of experience
of the nurse practitioners. Three out of five nurse practitioners had less than 3 years of
practice experience. This could have decreased the scores due to the lack of experience.
Although this may have been a limitation, this could confirm that the need here is even
greater. Implications resulting from these findings include individual and organizational
use of the guidelines, nurse practitioner growth and improvement in confidence when
treating PCOS, and educational growth for ancillary staff. This will benefit the patients
and the community. The continuation of this study could provide more data to support
the need for a change and the initiation of a policy. It could help to display concrete
evidence that shows a decrease in BMI, decrease in insulin levels, and increases in
fertility. These positive implications can be a great change in the rural area.
Recommendations
A recommended solution to the lack of knowledge of diagnosis and treatment of
PCOS would be the use of the guidelines/algorithm developed from the Endocrine
Society Task Force (Appendix C). Healthcare education is one key to ensuring quality of
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life, improving patient outcomes, and protecting individuals from harm (Grimm, 2014).
Clinical practice guidelines aim to achieve improved quality care, while reducing
healthcare (Keffer, 2001). Following the guidelines provided and implementing this as a
policy, after the completion of the study, would ensure that providers are ordering the
necessary test. This would aid in them in making the appropriate diagnosis and treatment
plans. As providers implement the use of the guidelines, if anything falls outside of the
guidelines, the provider will still have the option of referring directly to the Endocrine
Society Task Force recommendations
Strengths and Limitations of the Project
Strengths
One of the strengths of this project was that the topic gained the interest of the
doctor, nurse practitioners, and other nursing staff. They were all willing to participate in
the questionnaires and education session. Another strength of this project was the
accessibility of the CEO, medical director, and staff. This allowed the project to flow
smoothly due to their accessibility and ease to work with. Comments from the nurse
practitioners and medical director indicated the need for this project due to the statistics
surrounding the diagnosis.
Limitations
One limitation of this project was the small sample size of doctors and nurse
practitioners who participated. This practice only has one doctor, five nurse practitioners,
one nurse, one certified nursing assistant, and two medical assistances. Another
limitation of this project was that some of the nurse practitioners had less than 3 years of
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experience. Not having as much experience with patients with PCOS could have been
reflected in the pre education questionnaire scores.
Future Recommendations
There are some recommendations that could be made for future projects
addressing similar topics and using similar methods. One recommendation would be to
implement this project at a larger practice. I would also recommend limiting the
questionnaires to the providers including doctors and nurse practitioners with at least 5
years of experience.
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Section 5: Dissemination Plan
Dissemination is an important part of this entire project. It must be performed in
a proper manner. Two of the key reasons for disseminating are to share the information
with others in the community and to present the information to stakeholders and the
academic community (Zaccagnini & White, 2011). The method of dissemination will be
a presentation by using Power Point software and talking through the presentation or a
poster board presentation. I will be present the reason for the study, the data collected
from the nurse practitioners and the scores from the questionnaires. The guidelines taken
from the recommendations of the Endocrine Society Task Force will be reiterated. Due
to the nature of the product, the audience who would be appropriate for dissemination
would be nurse practitioners and nurses who diagnose and treat patients with PCOS.
Nurse practitioners who work in obstetrics, gynecology, and family medicine would
benefit the most from this dissemination. To help broaden the nursing profession,
vendors could include continuing education conferences and even visits to offices that
could provide a conference room.
Another idea for dissemination includes writing an article for publication in a
nursing journal. This would allow for more nurses and nurse practitioners to have access
to the information. Publication could be a useful and effective way of disseminating
information to audiences who match the needs (Zaccagnini & White, 2011).
Analysis of Self
Over the course of this project I had the sole responsibility of ensuring that the
project first identified a problem, displayed a gap in practice, gathered data on the topic,
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and implemented a project, which supported the idea that this problem must be
addressed. The development, implementation, and analysis provided me a learning
opportunity. I have had leadership roles and opportunities in my health career; however
this project supported my growth towards thinking as a scholar. The American
Association of Colleges of Nursing (AACN) Essentials discusses the DNP- prepared
nurses role in the scientific underpinnings of nursing practice. It discusses the wide array
of knowledge that the DNP prepared nurse has and the ability to translate that knowledge
quickly and effectively (AANP, 2006). AANP also addresses research and EBP (AANP,
2006).
This project encouraged me to become a better nurse practitioner, scholar, and
project manager. As a nurse practitioner I was made more aware of the importance of
following guidelines when appropriate. Each clinical experience allowed me to gain
insight from other leaders and scholars. This not only allowed me to see how things were
done, but also increased my confidence in myself. I started to gain the confidence and
belief in myself that I could actually complete this challenging project. As I progressed, I
gained enough confidence to speak with those in prestigious positions. I was able to
speak with the CEO, medical director, office manager, and providers at a facility. I had
support from my clinical preceptor, chair, and committee members, which helped
strengthen this project. One of my professional goals is to also become an instructor in a
DNP program. I can only hope to be as supportive and encouraging to upcoming
doctoral of nursing students as everyone has been to me.
Challenges
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Challenges were present during the course of this project. This is usually the case
with any large project. One thing that I found challenging was locating a facility that
would allow me to implement my project. Many facilities did not want to take on the
additional responsibility of having a student come in and implement a project. Another
challenge that I encountered was trying to find the time to work on my project
simultaneously with other didactic assignments. It became necessary to schedule time
specifically for my project. Despite the challenges that presented, I was able to overcome
them.
Solutions
The challenge of locating a facility was a difficult one; however, I was able to
overcome this challenge by meeting with the CEO of a facility. After hearing my plans
he approved. He as well as his office manager was both impressed and were immediately
ready to move forward. As mentioned previously, to solve my time management
problem, I found that I had to schedule time just to work on my project with no
distractions.
Insight
There was much insight gained throughout this entire process. One insight that I
gained was the ability to carry out a quality improvement project from start to finish. I
also gained insight on data collection and analysis. I gained a large amount of patience
during this process. I also learned how to manage disappointment by using it as fuel to
work harder.

27
Summary
PCOS is a disorder affecting many women of reproductive age (Health Grades,
2014). When left untreated women are at high risk for complications, which includes
infertility (Health Grades, 2014). Clinical practice guidelines are in place to optimize
patient care; however they are not always followed (Up-To-Date, 2016). Some providers
are not aware that recommended guidelines exist as they apply to the diagnosis and
treatment of PCOS. When it comes to the prevention of the complications and increasing
fertility in these women, the use of these guidelines could be what makes the biggest
difference in their outcome.
A group of providers were evaluated, educated, and then reevaluated on their
knowledge of PCOS diagnosis and treatment. They were then given an education session
on the topics. The providers were given education material as well as the guidelines.
They were then reevaluated on the diagnosis and treatment of PCOS with the same tool
used prior. I found that providers did not know as much as they originally thought
regarding the topic, which confirmed the need to implement these guidelines into policy
after the facility carries out the remainder of their portion of the project. This includes
the selection of patients, implementation of the guidelines, and collecting patient trends
on identified values over the course of a year. The providers as well as the CEO, medical
director, and office manager were provided a satisfaction survey. It was used to
determine if I developed effective quality improvement planning regarding the adaption
of the PCOS guidelines and an educational program for the providers. The selected
persons completing the survey were to take things such as the synthesis and leveling of
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evidence into consideration. This EBP quality improvement project has the potential to
positively influence nursing practice and improve overall outcomes for patients with
PCOS.
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Appendix A: Pre and Post Test Given
TEST	
  
Polycystic	
  Ovary	
  Syndrome	
  (Take	
  the	
  same	
  test	
  after	
  reading	
  material)	
  
1) What is the name of the criteria used to diagnose PCOS?
A. DSM-5
B. SAS
C. PHQ-9
D. Rotterdam

2) Name one clinical manifestation used for the diagnosis of PCOS in
adolescent girls.
_________________________	
  
3) What are some possible complications of PCOS?
A. Increased fertility, hyperlipidemia, hypertension, insulin resistance
B. decreased fertility, obesity, obstructive sleep apnea, endometrial cancer
C. weightloss, flushing, abnormal uterine bleeding, insulin resistance
D. obesity, abnormal uterine bleeding, increased fertility, insulin resistance
4) Women with PCOS do NOT have a higher cardiovascular risk than
women without PCOS?
A. True
B. False
5) Which symptoms are clinical manifestations of hyperandrogenism?
Mark all that apply
A. Alopecia
B. Acne
C. Heat intolerance
D. Hirsutism
E. Weightloss
F. Flushing
6) What is the first line treatment therapy for management of PCOS in
women with out acne, not trying to conceive?
A. Metformin
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B. Clomid
C. Lifestyle modifications (diet/exercise)
D. Letrozole
7) What is the first line treatment therapy for management of PCOS in
women with menstrual abnormalities and hirsutism/acne, who are not
trying to conceive?
A. Metformin
B. Hormonal Contraceptives
C. Lifestyle modifications (diet/exercise)
D. Clomid
8) What should be the next treatment therapy ordered for management of
PCOS in women with T2DM or IGT who fail lifestyle modifications?
A. Fasting
B. Insulin
C. Metformin
D. Low carbohydrate diet
9) What combination therapy can be used to in women with PCOS to
increase fertility and prevent ovarian hyperstimulation syndrome?
A. Metformin and Clomid
B. Metformin and Insulin
C. Metformin and rosiglitazone
D. Insulin and pioglitazone
10) PCOS is estimated to be the most common cause of anovulatory
dysfunction.
A. True
B. False
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Appendix B: Satisfaction Survey
Satisfaction	
  Survey	
  
Please	
  answer	
  yes	
  or	
  no	
  to	
  each	
  question.	
  

1.)	
  The	
  student	
  DID	
  display	
  effective	
  quality	
  improvement	
  planning	
  regarding	
  
the	
  need	
  for	
  the	
  adoption	
  of	
  the	
  PCOS	
  practice	
  guideline/algorithm?	
  	
  	
  	
  Yes	
  or	
  
No	
  

2.)	
  The	
  student	
  provided	
  expert	
  educational	
  material	
  that	
  was	
  clear	
  and	
  
concise?	
  	
  Yes	
  or	
  No	
  
3.)	
  The	
  student	
  was	
  professional	
  and	
  displayed	
  adequate	
  organizational	
  and	
  
leadership	
  skills.	
  Yes	
  or	
  No	
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Appendix C: Guidelines
Educational	
  Material	
  and	
  Guidelines	
  

What	
  are	
  common	
  signs	
  and	
  symptoms	
  of	
  polycystic	
  ovary	
  
syndrome	
  (PCOS)?	
  
Common	
  PCOS	
  signs	
  and	
  symptoms	
  include	
  the	
  following:	
  
• Irregular menstrual periods
• Infertility—PCOS is one of the most common causes of female infertility.
• Obesity—Up to 80% of women with PCOS are obese.
• Excess hair growth on the face, chest, abdomen, or upper thighs—This condition,
called hirsutism, affects more than 70% of women with PCOS.
• Severe acne or acne that occurs after adolescence and does not respond to usual
treatments
• Oily skin
• Patches of thickened, velvety, darkened skin called acanthosis nigricans
• Multiple small cysts on the ovaries

What	
  causes	
  PCOS?	
  

Although	
  the	
  cause	
  of	
  PCOS	
  is	
  not	
  known,	
  it	
  appears	
  that	
  PCOS	
  may	
  be	
  related	
  to	
  
many	
  different	
  factors	
  working	
  together.	
  These	
  factors	
  include	
  insulin	
  resistance,	
  
increased	
  levels	
  of	
  hormones	
  called	
  androgens,	
  and	
  an	
  irregular	
  menstrual	
  cycle.	
  
PCOS	
  Complications	
  Include	
  
•
•
•
•
•
•
•
•
•

Infertility
Obesity
Obstructive sleep apnea
Hypertension
Diabetes
Endometrial hyperplasia/cancer
Fatty Liver Disease
Mood disturbances and depression
Hyperlipidemia
Diagnosis	
  Criteria	
  

The	
  most	
  common	
  diagnostic	
  criteria	
  used	
  are	
  Rotterdam	
  criteria.	
  Patient	
  needs	
  2	
  
out	
  of	
  3	
  
•

Oligo or anovulation
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•
•

Clinical and/or biochemical signs of hyperandrogenism (hirsutism, acne,
alopecia).
Transvaginal ultrasonographic polycystic ovaries and exclusion of other
etiologies.
Work-‐Up	
  

Screening	
  workup	
  should	
  include	
  hcg,	
  TSH,	
  prolactin,	
  FSH,	
  DHEAS,	
  17-‐OH	
  
progesterone,	
  and	
  testosterone	
  level.	
  	
  LH	
  determination	
  may	
  be	
  ordered	
  but	
  is	
  not	
  
necessary.	
  Keep	
  in	
  mind	
  that	
  drugs	
  that	
  can	
  alter	
  results	
  include	
  (oral	
  
contraceptives,	
  Steroids,	
  and	
  antidepressants).	
  	
  Consider	
  fasting	
  serum	
  glucose,	
  
insulin	
  level,	
  and	
  plasminogen	
  activator	
  inhibitor-‐1	
  determinations	
  to	
  establish	
  
presence	
  of	
  insulin	
  resistance	
  and	
  glucose	
  intolerance.	
  
Treatment	
  of	
  PCOS	
  
Lifestyle	
  modifications	
  such	
  as	
  weight	
  loss	
  and	
  increased	
  exercise	
  in	
  conjunction	
  
with	
  a	
  change	
  in	
  diet	
  consistently	
  reduce	
  the	
  risk	
  of	
  diabetes.	
  This	
  approach	
  has	
  
been	
  found	
  to	
  be	
  comparable	
  to	
  or	
  better	
  than	
  treatment	
  with	
  medication	
  and	
  
should	
  therefore	
  be	
  considered	
  first-‐line	
  treatment	
  in	
  managing	
  women	
  with	
  
polycystic	
  ovarian	
  syndrome	
  (PCOS).	
  
The	
  Endocrine	
  Society	
  Task	
  Force	
  recommends	
  HCs	
  (i.e.,	
  oral	
  contraceptives,	
  patch,	
  
or	
  vaginal	
  ring)	
  as	
  first-‐line	
  management	
  for	
  the	
  menstrual	
  abnormalities	
  and	
  
hirsutism/acne	
  of	
  PCOS,	
  which	
  treat	
  these	
  two	
  problems	
  concurrently.
The	
  Endocrine	
  Society	
  Task	
  Force	
  suggest	
  against	
  the	
  use	
  of	
  metformin	
  as	
  a	
  first-‐
line	
  treatment	
  of	
  cutaneous	
  manifestations,	
  for	
  prevention	
  of	
  pregnancy	
  
complications,	
  or	
  for	
  the	
  treatment	
  of	
  obesity;	
  however,	
  they	
  do	
  recommend	
  
metformin	
  as	
  in	
  women	
  with	
  PCOS	
  who	
  have	
  T2DM	
  or	
  IGT	
  who	
  fail	
  lifestyle	
  
modification.	
  For	
  women	
  with	
  PCOS	
  with	
  menstrual	
  irregularity	
  who	
  cannot	
  take	
  or	
  
do	
  not	
  tolerate	
  HCs,	
  we	
  suggest	
  metformin	
  as	
  second-‐line	
  therapy.	
  
The	
  Endocrine	
  Society	
  Task	
  Force	
  recommends	
  clomiphene	
  citrate	
  (or	
  comparable	
  
estrogen	
  modulators	
  such	
  as	
  letrozole)	
  as	
  the	
  first-‐line	
  treatment	
  of	
  anovulatory	
  
infertility	
  in	
  women	
  with	
  PCOS.	
  
	
  
	
  We	
  suggest	
  the	
  use	
  of	
  metformin	
  as	
  an	
  adjuvant	
  therapy	
  for	
  infertility	
  to	
  prevent	
  
ovarian	
  hyperstimulation	
  syndrome	
  (OHSS)	
  in	
  women	
  with	
  PCOS	
  undergoing	
  in	
  
vitro	
  fertilization.	
  
Use	
  of	
  other	
  drugs	
  
	
  We	
  recommend	
  against	
  the	
  use	
  of	
  insulin	
  sensitizers,	
  such	
  as	
  inositols	
  (due	
  to	
  lack	
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of	
  benefit)	
  or	
  thiazolidinediones	
  (given	
  safety	
  concerns),	
  for	
  the	
  treatment	
  of	
  PCOS.	
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Appendix D: Test Results
Pre and Post Test Scores
Nurse 1

Nurse 2

Nurse 3

80%

70%

90%

70%
3

Pre
# Missed

2

3

1

Post

100%

100%

100%

# Missed

0

0

0

Nurse 4

100%
0

Nurse 5

60%

Average

74%

4

100%

100%

0

This data displays the test scores achieved by each of the 5 nurse practitioners. Scores
ranged from 60% to 90% prior to the education session. The post scores display a perfect
score of (100%) for all of the nurse practitioners.
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Appendix E: Dissemination Poster

